31 Jul 2012 15:02
Tissue Regenix Group Plc
("Tissue Regenix" or "The Company")
Director Share Purchase
The Company announces that on 31 July 2012 John Samuel, Executive Chairman of Tissue Regenix Group Plc, acquired 290,000 ordinary shares of 0.5 pence at a price of 10.25 pence per ordinary share.
Following the transaction John Samuel holds 13,138,928 ordinary shares and has a beneficial interest in a further 10,740,000 ordinary shares which together represent 3.66% of the Company's issued share capital.
Contact
Tissue Regenix Group Plc, Antony Odell
| +44 (0) 1904 435176 |
Peel Hunt LLP, James Steel / Vijay Barathan
| +44 (0) 20 7418 8852 |
|
|